Paul Knoebl, MD

Professor
Department of Medicine 1, Division of Hematology and Hemostasis, Medical University of Vienna, Vienna, Austria

Paul Knoebl, MD
Associate Professor, Medical University of Vienna, Department of Medicine 1, Division of Haematology and Haemostasis, Vienna, Austria

Prof. Knoebl’s interests are focused on clinical and basic research on blood coagulation, fibrinolysis, endothelial cell function, haemophilia, diabetes mellitus, haematologic malignancies, intensive care medicine, thrombotic thrombocytopenic purpura and coagulation lab techniques. He has over 220 scientific articles and book chapter publications been invited to multiple lectures and lots of oral presentations on national and international scientific meetings, and serves as reviewer and section editor for several important medical journals.
Prof. Knöbl has particiated in many clinical trials (all phases) as prinipal investigator or coinvestigator.
He is a member of the International Society on Thrombosis and Hemostasis; Society on Thrombosis and Hemostasis (GTH); Austrian Society of Internal Medicine; Austrian Society of Hematology and Oncology.

Presentation(s):

• OC 04.1 - Management of thrombotic thrombocytopenic purpura (TTP) without plasma exchange: an update on the Austrian experience

  Saturday, July 9, 2022
  1:00 PM – 1:15 PM

• SSC 08.04 - Should Caplacizumab Be Used up Front in All Patients With Auto-Immune Thrombotic Thrombocytopenic Purpura (iTTP): Point/Counterpoint

  Sunday, July 10, 2022
  4:55 PM – 5:05 PM

• PB0002 - Emicizumab for the treatment of acquired hemophilia A: an update of the Vienna experience

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0303 - Alternate-day dosing of caplacizumab for immune-mediated thrombotic thrombocytopenic purpura

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM